Sorry, you need to enable JavaScript to visit this website.

Pharmacy Resources for Dexcom G7

Are you looking for Pharmacy Resources for Dexcom G6? Click here.


more accurate,†,1
better outcomes2-6 

Dexcom G7 real-time Continuous Glucose Monitoring (rtCGM) System, sold exclusively in pharmacies, is our most accurate rtCGM system†,1 and was designed to take the guesswork out of managing diabetes. The new all-in-one sensor continuously measures and sends glucose data wirelessly to a smart device or optional receiver, without requiring routine fingersticks* or scanning.

Dexcom G7 sensor and Dexcom G7 app on a smart device (not included).
Accuracy Icon

The most accurate
rtCGM system*,1

Lower A1C Icon

Greater A1C reduction vs. Freestyle Libre isCGM¶,8


Alarms Icon

Only Dexcom real-time rtCGM has a predictive Urgent Low Soon alert9 

Easy Icon

Easier than ever to use – and to continue using.††,11 


Reduces Hypoglycemia Icon

Less hypoglycemia§

Increase Time in Range Icon

More time in range6

Dexcom G7 Certification

This 15-minute course will introduce you to the features and benefits of the Dexcom G7.

Dexcom G7

Prescribed by hand or digitally through select EMR systems, and fulfilled at pharmacy.

G7 Applicator

Dexcom G7

The Dexcom G7 all-in-one sensor with built-in transmitter is sold in packs of one, with up to 10 days of use per sensor. The sensor packaging includes important Instructions for use in English and French. 

90-DAY RX FILL: Includes nine (9) Dexcom G7 Sensors 

30-DAY RX FILL: Includes three (3) Dexcom G7 Sensors  

G7 Billing PINs
for Pharmacy Adjudication


PINDexcom G7
Dexcom G7
BC PharmaCare4312000743120006
Quebec (AQPP)0111106401111063
Rest of Canada9779897297798973


G7 Retail Box

Dexcom G7 Sensor Replacement Program 

We are making it easier for Dexcom G7 real-time Continuous Glucose Monitoring (rtCGM) System users to obtain authorized replacement sensors. Effective immediately, Dexcom G7 replacement sensors can be picked up at community pharmacies across Canada.

Dexcom patients will benefit from the convenience of obtaining their sensor replacement at a pharmacy of their choice, and pharmacies across Canada will obtain a reasonable product markup and dispensing fee for the service provided.

New Patient Benefit Program
Covers Up to 20% of Dexcom G7 Sensors

The new Dexcom G7 Patient Benefit Program helps make the Dexcom G7 rtCGM System more accessible and affordable. The program will cover up to 20% of the cost* of Dexcom G7 sensors when presented at the pharmacy. Healthcare providers can provide Dexcom G7 users with printed or digital certificates that will help to reduce or eliminate their out-of-pocket costs.

Wholesaler Order Codes


 Product Description
Order CodesDexcom G7 SensorDexcom G7 Receiver
Best Buy Medical SuppliesDEX STP-GT-008DEX STK-GT-113
Distribution PharmaplusSTP-GT-008STK-GT-113
Imperial (AB)386360386638
Imperial (BC)386360386638
Jean Coutu 751324752088
Kohl & Frisch168120168119
LPG Inventory Solutions3984339844
Shoppers Drug Mart Matrix DC2156699121566800
Pharmacy Tools & Information Sheets
Pharmacist One Pager
G7 Pharmacy Toolkit
Patient onboarding
G7 Patient Onboarding Handout
G7 Pharmacy Prescription Request
G7 Patient Identification Tool
G7 Free Sample Program
Keep up with the latest news and information.

Stay up to date
with Dexcom

Sign up to stay up to date with the latest CGM news, product updates and educational events.
Please see for information on our consumer products.

* If glucose alerts and readings from the G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. 
† For a list of compatible smart devices, visit 
‡ When compared with CGM systems commercially available in Canada as of October 2023.  
§ This predictive alert can be triggered with impending hypoglycemia (glucose of 3.1 mmol/L or below is predicted to occur within the next 20 minutes). 
¶ Retrospective, real-world observational analysis of the Canadian LMC Diabetes Registry using the medical records of 143 consenting CGM-naïve adults with type 1 diabetes (T1D) in each rtCGM and isCGM matched cohorts. To be eligible, people must have had: diagnosis of T1D >12 months, baseline A1C >7.0%, and 1 or more completed HbA1c measurements 6 months prior and 6-12 months post-index date. 
†† Based on data from Dexcom CGM users in the U.S.

1 Dexcom, data on file, 2023.
2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Martens T, et al. JAMA. 2021;325(22):2262-2272.
5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396.
6 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
7 Heinemann L, et al. Lancet. 2018;391:1367-1377.
8 Dexcom G7 CGM System User Guide.
9 Dexcom G7 CGM System User Guide. 
10 Freestyle Libre 2 Flash Glucose Monitoring System User’s Manual. 
11 Dexcom, U.S. data on file, 2022..